Work Here?
Overview
Truveris provides technology and data analytics for the prescription drug sector, working within the pharmacy supply chain. It serves payers, brokers, and manufacturers with insights and tools to manage pharmacy benefits more effectively. The core offering includes technology solutions and data analytics services for cost containment, clinical guidance, and strategic program design, plus patient access programs that help pharmaceutical brands reach patients and anticipate market shifts. Truveris helps clients stay ahead of regulatory changes (such as FDA recalls) and navigate evolving pharmacy rules. Its goal is to deliver clear, confident insights into pharmacy benefits to improve employee health, productivity, and satisfaction while supporting client growth with branded programs and advisory services.
About Truveris
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Series E
Total Funding
$69.1M
Headquarters
New York City, New York
Founded
2009
Get referred to Truveris
See people who can refer or advise you
Simplify's Take
What believers are saying
- Minnesota’s 52,000-employee selection proves Truveris still wins public-sector pharmacy contracts.
- The March 2026 Center of Excellence supports heavier advisory demand from GLP-1 and biosimilar churn.
- The 2026 CAA and FTC-ESI changes expand demand for independent PBM oversight now.
What critics are saying
- Truveris’s 2026 CEO information is inconsistent, signaling governance or communication problems.
- PBM reform and TrumpRx commoditize transparency services, squeezing Truveris’s advisory differentiation by 2026.
- A failed scaling cycle after the 2024-2026 growth hires would cripple employer retention.
What makes Truveris unique
- Truveris runs independent PBM procurement and oversight, avoiding carrier-owned conflicts.
- Its 2026 Center of Excellence bundles PharmDs, analytics, and contract expertise.
- The Mark Cuban Cost Plus Drugs collaboration strengthens transparent-pharmacy positioning with employers.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$69M
Below
Industry Average
Funded Over
6 Rounds
First Round CapitalIndustry standards
Growth & Insights and Company News
6 month growth
↓ -2%1 year growth
↓ -1%2 year growth
↑ 0%Truveris collaborates with Mark Cuban Cost Plus Drug Company to reduce pharmacy benefits spend.
Truveris, a Wilmington, DE-based company specializing in pharmacy cost containment, raised $15M in Series E funding. The round was led by Canaan Partners and New Leaf Venture Partners. The funds will support corporate development and operational growth. CEO Nanette Oddo stated that the financing validates their solutions and growth potential, and they aim to transform and reduce pharmacy spend for employers and their plan members.
Truveris, a pharmacy cost containment and program performance company, raised $15 million in Series E funding led by Canaan Partners and New Leaf Venture Partners. The funding will support corporate development and operational growth. Truveris' platform replaces traditional pharmacy benefit manager models, providing transparency and savings. CEO Nanette Oddo highlighted the validation of their solutions and growth potential. For more information, contact [email protected].
Truveris, a Wilmington, DE-based company which specializes in pharmacy cost containment and program performance, raised $15M in Series E funding.
Truveris has secured $15 million in Series E funding led by Canaan Partners and New Leaf Venture Partners. The investment will support Truveris' corporate development and operational growth, enhancing its pharmacy benefit solutions for employers. CEO Nanette Oddo highlighted the validation of their solutions and growth potential. Stephen Bloch of Canaan Partners emphasized Truveris' focus on using technology to reduce pharmacy spend for employers and their plan members.
There are no jobs for Truveris right now.
Find jobs on Simplify and start your career today
About Truveris
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Series E
Total Funding
$69.1M
Headquarters
New York City, New York
Founded
2009
There are no jobs for Truveris right now.
Find jobs on Simplify and start your career today